International Patent: CHI3L1-TARGETING OLIGONUCLEOTIDES AND METHODS OF USING THE SAME

GENEVA, June 26 -- AMYLYX PHARMACEUTICALS, INC. filed a patent application (US2025/058434) for “CHI3L1-TARGETING OLIGONUCLEOTIDES AND METHODS OF USING THE SAME”. With publication no. WO/2026/122969, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....